SCHEMBL1053950

SCHEMBL1053950

[NH]C(=O)N1CCCC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16096027 0.79
SCHEMBL5017013 0.77
SCHEMBL1053952 0.77
Hydrochloric Acid SCHEMBL27832717 0.76 POLB (0.36)
SCHEMBL4028301 0.74 HPGD (0.37)
SCHEMBL3109587 0.73 GAA (0.36)
SCHEMBL3574422 0.73
SCHEMBL28134219 0.72 ACE (0.39)
SCHEMBL31122937 0.71 HPGD (0.35)
Hydrochloric Acid SCHEMBL21811983 0.71 GAA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2368880-A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor Japan Tobacco, Inc. (JP) 2011-09-28 EP disclosed
US-7872004-B2 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2011-01-18 US disclosed
EP-2033954-A1 6-(HETEROCYCLE-SUBSTITUTED BENZYL)-4-OXOQUINOLINE COMPOUND AND USE OF THE SAME AS HIV INTEGRASE INHIBITOR Japan Tobacco, Inc. (JP) 2009-03-11 EP disclosed
US-20080207618-A1 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor JAPAN TOBACCO INC. (JP) 2008-08-28 US disclosed